1-14 of 14
Emmanuelle Tchernonog
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time-limited acalabrutinib monotherapy in frail patients with previously untreated chronic lymphocytic leukemia: Primary endpoint analysis of the randomized STAIR trial.

Free
Romain Guieze, Emmanuelle Ferrant, Fatiha Merabet, Lysiane Molina, Driss Chaoui, Pierre Feugier, Therese Aurran-Schleinitz, Safia Chebrek, Hugo Gonzalez, Aline Clavert, Marlene Ochmann, Kamel Laribi, Anne-Sophie Michallet, Vincent Levy, Benedicte Hivert, Caroline Dartigeas, Laurence Simon, Damien Roos Weil, Anne Quinquenel, Anne Violaine Doncker, Julie Gay, Antoine Bonnet, Marie-Sarah Dilhuydy, Emmanuelle Tchernonog, Bernard Drenou, Sophie de Guibert, Laurence Sanhes, Stephane Lepretre, Olivier Tournilhac, Florence Nguyen-Khac, valerie rouille, Marie Poinsignon, Cabarrou Bastien, Loic Ysebaert
Journal: Blood
Blood (2025) 146 (Supplement 1): 684.
https://doi.org/10.1182/blood-2025-684
Published: 2025
Journal Articles

MCL1 copy number gain is a recurrent mark of venetoclax resistance in patients with chronic lymphocytic leukemia

Free
Carolyne Croizier, Manon Garcia, Stéphanie Poulain, Loic Ysebaert, Sylvain Carras, Damien Roos Weil, Anne Quinquenel, Anne-Sophie Michallet, Emmanuelle Tchernonog, Pierre Morel, Adrien Chauchet, Pierre Feugier, Nataliya Dmytruk, Morgane Nudel Ortmans, Elise Chapiro, Grégory Lazarian, Olivier Tournilhac, Marc Berger, Bruno Pereira, Ludivine Paris, Nathan Papon, Inès Ramos, Lauren Veronese, Romain Guieze
Journal: Blood
Blood (2025) 146 (Supplement 1): 3875.
https://doi.org/10.1182/blood-2025-3875
Published: 2025
Journal Articles

Real-world (RW) use of fixed-duration (FD) ibrutinib+venetoclax (Ibr+Ven) in patients (pts) with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Pooled analysis of REALITY-worldwide (WW) and REALITY-2 prospective cohort studies

Free
Catherine Thieblemont, Emmanuelle Tchernonog, Talha Munir, Oliver Miles, Ingo Schwaner, Ugo Consoli, Vanessa Innao, Anna Mele, Danielle De Farias, Adriana Scheliga, Neil Kay, Ahmed Absi, Galia Stemer, Tamar Tadmor, Mark Hoffman, Brian Koffman, Boo Messahel, Sowmya Srikanthan, Erin Franceschini, Christopher Abbazio, Ping Xu, Christoph Tapprich, Claire Kavanagh, Mohamed Fouad, Lori Parisi, Mark Wildgust, Paolo Ghia
Journal: Blood
Blood (2025) 146 (Supplement 1): 3903.
https://doi.org/10.1182/blood-2025-3903
Published: 2025
Journal Articles

Outcomes with Venetoclax-Based Treatment in Patients with Covalent Bruton Tyrosine Kinase Inhibitor (cBTKi)-Treated, Chemotherapy-Naïve Chronic Lymphocytic Leukemia (CLL): An International Retrospective Study

Free
Paul J. Hampel, Kari G. Rabe, Romain Guieze, Yucai Wang, Emmanuelle Ferrant, Saad S. Kenderian, Marie Sarah Dilhuydy, Eli Muchtar, Anne-Sophie Michallet, Jose F. Leis, Luca Inchiappa, Mazie Tsang, Aline Clavert, Talal Hilal, Stephane Lepretre, Ricardo D. Parrondo, Emmanuelle Tchernonog, Amber Koehler, Lin Wang, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Luc-Matthieu Fornecker, Sameer A. Parikh, Loic Ysebaert
Journal: Blood
Blood (2024) 144 (Supplement 1): 1856.
https://doi.org/10.1182/blood-2024-198200
Published: 2024
Journal Articles

5-y Follow-up of Combination of Ibrutinib, Obinutuzumab and Venetoclax for Patients with Newly Diagnosed Mantle Cell Lymphoma, the Oasis Trial

Free
Benoit Tessoulin, Franck Morschhauser, David Chiron, Krimo Bouabdallah, Guillaume Cartron, Cedric Rossi, Caroline Milin, Ludovic Fouillet, Charles Herbaux, Emmanuelle Tchernonog, Rory McCulloch, Thomas Gastinne, Mary B. Callanan, Steven Le Gouill
Journal: Blood
Blood (2024) 144 (Supplement 1): 1657.
https://doi.org/10.1182/blood-2024-206778
Published: 2024
Journal Articles

Outcomes of CLL Patients Exposed to Venetoclax+/-R after Ibrutinib in France: The Resist Retrospective Study from the Filo-CLL Group

Free
Loic Ysebaert, Emmanuelle Ferrant, Marie Sarah Dilhuydy, Anne-Sophie Michallet, Luca Inchiappa, Romain Guieze, Emmanuelle Tchernonog, Ana Cavillon, Marie Christine Bene, Luc-Matthieu Fornecker
Journal: Blood
Blood (2023) 142 (Supplement 1): 3273.
https://doi.org/10.1182/blood-2023-180696
Published: 2023
Journal Articles

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

Free
Matthew R. Wilson, Toby A. Eyre, Amy A. Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Nicolás Martinez-Calle, Gavin Preston, Matthew Ahearne, Elisabeth Schorb, Marie-Pierre Moles-Moreau, Matthew Ku, Chiara Rusconi, Jahanzaib Khwaja, Mayur Narkhede, Katharine L. Lewis, Teresa Calimeri, Eric Durot, Loïc Renaud, Andreas Kiesbye Øvlisen, Graham McIlroy, Timothy J. Ebsworth, Johnathan Elliot, Anna Santarsieri, Laure Ricard, Nimish Shah, Qin Liu, Adam S. Zayac, Francesco Vassallo, Laure Lebras, Louise Roulin, Naelle Lombion, Kate Manos, Ruben Fernandez, Nada Hamad, Alberto Lopez-Garcia, Deirdre O'Mahony, Praveen Gounder, Nathalie Forgeard, Charlotte Lees, Kossi Agbetiafa, Tim Strüßmann, Thura Win Htut, Aline Clavert, Hamish Scott, Anna Guidetti, Brett R. Barlow, Emmanuelle Tchernonog, Jeffery Smith, Fiona Miall, Christopher P. Fox, Chan Y. Cheah, Tarec Christoffer El Galaly, Andrés J.M. Ferreri, Kate Cwynarski, Pamela McKay
Journal: Blood
Blood (2022) 139 (16): 2499–2511.
https://doi.org/10.1182/blood.2021014506
Published: 2022
Includes: Supplemental data
Journal Articles

Safety and Efficacy of Venetoclax-Based Treatment in Elderly CLL Patients: A Retrospective Study from the Filo Group

Free
Charlotte Doublet, Marie-Sarah Dilhuydy, Emmanuelle Ferrant, Pierre Feugier, Alexandra Fayault, Philippine Robert, Stephane Lepretre, Alain Delmer, Cécile Tomowiak, Romain Guieze, Kamel Laribi, Marguerite Vignon, Aline Clavert, Fontanet Bijou, Daniel Re, Diane Lara, Fatiha Merabet, Emmanuelle Tchernonog, Caroline Dartigeas, Anne-Sophie Michallet, Anne Quinquenel
Journal: Blood
Blood (2021) 138 (Supplement 1): 3747.
https://doi.org/10.1182/blood-2021-149640
Published: 2021
Journal Articles

Coagulopathy Following Chimeric Antigen Receptor T Cell Therapy in R/R Adult B Cell Malignancies: A Single Center Experience

Free
Safia Belbachir, Jean Jacques Tudesq, Sylvain Lamure, Pierre Rocanieres, Elena Properzi, Patrice Ceballos, Nathalie Fegueux, Eve Gehlkopf, Franciane Paul, Emmanuelle Tchernonog, Alexandre Theron, Anne-Charlotte Teyssier, Isabelle Diaz, Aguilar-Martinez Patricia, Charles Herbaux, Guillaume Cartron
Journal: Blood
Blood (2021) 138 (Supplement 1): 4839.
https://doi.org/10.1182/blood-2021-152465
Published: 2021
Journal Articles

Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial

Free
Clinical Trials & Observations
Steven Le Gouill, Franck Morschhauser, David Chiron, Krimo Bouabdallah, Guillaume Cartron, Olivier Casasnovas, Caroline Bodet-Milin, Sylviane Ragot, Céline Bossard, Nathalie Nadal, Charles Herbaux, Benoit Tessoulin, Emmanuelle Tchernonog, Cédric Rossi, Rory McCulloch, Thomas Gastinne, Mary B. Callanan, Simon Rule
Journal: Blood
Blood (2021) 137 (7): 877–887.
https://doi.org/10.1182/blood.2020008727
Published: 2021
Includes: Supplemental data
Journal Articles

Ibrutinib, Venetoclax Plus Obinutuzumab in Newly Diagnosed Mantle Cell Lymphoma Patients

Free
Steven Le Gouill, MD PhD, Franck Morschhauser, MD, Kamal Bouabdallah, MD, Guillaume Cartron, Olivier Casasnovas, MD, Thomas Gastinne, MD, Patrice Chevallier, MD, Cédric Rossi, MD PhD, Emmanuelle Tchernonog, MD, Rory McCulloch, FRCPath, MRCP, MBBS, Charles Herbaux, MD, David Chiron, PhD, Mary Callanan, PhD, Simon Rule
Journal: Blood
Blood (2019) 134 (Supplement_1): 1530.
https://doi.org/10.1182/blood-2019-125681
Published: 2019
Journal Articles

Outcome of Patients Receiving Venetoclax for Chronic Lymphocytic Leukemia (CLL) in Real-Life Clinical Practice: Results of the French ATU Program on Behalf of the Filo Group

Free
Florian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, MD, Sandy Amorim, MD, Florence Cymbalista, MD PhD, Charles Herbaux, MD, Sophie de Guibert, MD, Damien Roos-Weil, MD, Benedicte Hivert, MD, Thérèse Aurran, MD, Jehan Dupuis, MD, Anaise Blouet, MD, Emmanuelle Tchernonog, MD, Kamel Laribi, MD, Natalia Dmytruk, MD, Pierre Morel, Anne-Sophie Michallet, MD PhD, Caroline Dartigeas, MD, Laure Farnault, MD, Anne Lavaud, MD, Isabelle Plantier, MD, Jacques-Olivier Bay, MD PhD, Olivier Tournilhac, MD PhD, Alain Jacques Delmer, MD, Pierre Feugier, Loic Ysebaert, MD PhD, Romain Guieze, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5549.
https://doi.org/10.1182/blood-2018-99-118622
Published: 2018
Journal Articles

Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis

Free
Thomas Guerrero, MD, Michele Bibas, MD, Franco Baldini, MD, Guillaume Cartron, Kate Cwynarski, MD, Daan Dierickx, MD PhD, Frederick Lansigan, MD, Yevgeniy A Linnik, MD, Renzo Mogollon, MD, Jose Tomas Navarro, MD PhD, Slavisa Ninkovic, MBBS FRACP FRCPA, Adam J Olszewski, MD, John L. Reagan, MD, Emmanuelle Tchernonog, MD, Thomas Tousseyn, MD PhD, Jorge J. Castillo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1580.
https://doi.org/10.1182/blood.V130.Suppl_1.1580.1580
Published: 2017
Journal Articles

Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers

Free
Sylvain Chantepie, MD, Emmanuelle Tchernonog, MD, Frederic Peyrade, MD, Marie-Virginie Larcher, MD, Momar Diouf, MD, Luc Mathieu Fornecker, MD PhD, Roch Houot, MD PhD, Thomas Gastinne, MD, Carole Soussain, MD PhD, Sandra Malak, MD, Olivier Tournilhac, MD PhD, Caroline Delette, Ahmad Ibrahim, Anne-Claire Gac, MD, Jean-Pierre Vilque, MD, Mohamed Amine Bekadja, Rene-Olivier Casasnovas, MD, Remy Gressin, MD, Arnaud Jaccard, MD PhD, Benjamin Carpentier, Reda Garidi, MD, Bachra Choufi, MD, Stéphanie Guidez, MD, Adrian Tempescul, MD, Adrien Chauchet, MD, Emmanuel Gyan, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Krimo Bouabdallah, MD, Eric Durot, MD, Gandhi Damaj, MD
Journal: Blood
Blood (2016) 128 (22): 3450.
https://doi.org/10.1182/blood.V128.22.3450.3450
Published: 2016